Want to join the conversation?
$GERN's imetelstat portfolio of patents and related products have been licensed to Janssen Biotech. Janssen is conducting 2 clinical trials of imetelstat under agreement terms; IMbarkTM for patients with high risk myelofibrosis, and IMergeTM for patients with Intermediate-1 risk myelodysplastic syndromes.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.